ENGENSIS - Trademark Details
Status: 700 - Registered
Serial Number
87777607
Registration Number
5694789
Word Mark
ENGENSIS
Status
700 - Registered
Status Date
2019-03-12
Filing Date
2018-01-31
Registration Number
5694789
Registration Date
2019-03-12
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-10-02
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
FIRST, VIVIAN M
Statements
Goods and Services
Chemical reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; diagnostic preparations for medical purposes for detecting mutation in prion genes; preparations for medical purposes for detecting mutation in prion genes; chemical preparations for pharmaceutical purposes, namely, for painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; drugs for medical purposes, namely, prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; medicines for human purposes, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for diagnosis of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; ethical medicinal preparations, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for use in medical DNA analysis; genetic treatment pharmaceutical preparations
Goods and Services
Pharmaceutical research and development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research and development of vaccines and medicines; scientific research in the fields of biomedicine; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-02-09
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-09
Primary Code
042
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DANIEL P. MULLARKEY
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2017-12-22 | 40-2017-0165 | South Korea | True |
2017-12-22 | 40-2017-0165 | South Korea | True |
Trademark Events
Event Date | Event Description |
2018-02-03 | NEW APPLICATION ENTERED IN TRAM |
2018-02-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-04-24 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2018-05-01 | ASSIGNED TO LIE |
2018-05-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-05-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-05-14 | ASSIGNED TO EXAMINER |
2018-05-14 | NON-FINAL ACTION WRITTEN |
2018-05-14 | NON-FINAL ACTION E-MAILED |
2018-05-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-08-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-08-23 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-08-23 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-08-24 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-09-12 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-10-02 | PUBLISHED FOR OPPOSITION |
2018-10-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-11-27 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2018-12-21 | TEAS DELETE 1(B) BASIS RECEIVED |
2019-02-05 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2018-12-21 | NOTICE OF ALLOWANCE CANCELLED |
2019-02-05 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
2019-03-12 | REGISTERED-PRINCIPAL REGISTER |
2019-05-10 | REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED |
2019-06-19 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |